(Q36035803)

11 August 2017

1 reference

title

Loss of leptin actions in obesity: two concepts with cardiovascular implications (English)

1 reference

11 August 2017

0 references

Kamal Rahmouni

3

0 references

William G. Haynes

object named as

William G Haynes

series ordinal

4

0 references

author name string

Allyn L Mark

series ordinal

1

1 reference

PubMed ID

15702617

11 August 2017

Marcelo L G Correia

series ordinal

2

1 reference

PubMed ID

15702617

11 August 2017

language of work or name

1 reference

1 October 2004

1 reference

Clinical and Experimental Hypertension

11 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

26

1 reference

11 August 2017

7-8

1 reference

11 August 2017

629-636

1 reference

Positional cloning of the mouse obese gene and its human homologue

11 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Physiological response to long-term peripheral and central leptin infusion in lean and obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Identification and expression cloning of a leptin receptor, OB-R

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Chronic leptin infusion increases arterial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Pathophysiological role of leptin in obesity-related hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Leptin physiology: a second look

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Diseases of liporegulation: new perspective on obesity and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-200031948

21 January 2018

Identifiers

DOI

10.1081/CEH-200031948

1 reference

11 August 2017

1 reference

PubMed ID

15702617